Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20191123045476N3Phase 3Completed
Phase 3, open-label trial of platelet-rich plasma in endometriosis (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Serum anti-Mullerian hormone level and Antral follicle count. Started Dec 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20191123045476N3.